_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Entresto® (sacubitril/valsartan) resources

Explore our resources designed to provide useful information on Entresto and support with initiation and ongoing treatment.

You can download certain files below for you to share with your patients separately. In order to view these files, you will be required to register. Please do not share links to this website or screenshots with patients, as this website is intended for healthcare professionals only.

 

Thumbnail image of HCP’s guide to MyEntresto & YourChoice Engage document.

HCP’s guide to MyEntresto & YourChoice Engage

Request a copy for our introductory guide to MyEntresto & YourChoice Engage: our online patient resource designed to support you in empowering your patients to stay on top of their condition and treatment, with the aim of improving adherence. This outlines the key features of the platform, and how these can support your patients.

 

Thumbnail image of ENTRESTO Patient profiles document.

ENTRESTO patient profiles

Download our patient case study resource to learn how ENTRESTO can reduce the burden of heart failure and improve the quality of life in patients diagnosed with HFrEF.

 

Thumbnail image of ENTRESTO prescribe with confidence leave piece.

Prescribe with confidence

Download our ENTRESTO prescribing guidance leave piece, which includes information on recommended dosing, safety profile and dosing considerations.

 

Thumbnail image of Start with ENTRESTO leave piece.

Start with ENTRESTO

Download our guide to starting treatment with ENTRESTO, which summarises the data from key clinical trials and highlights the recommendations from the CaReMe UK Partnership, ACC, and ESC.

 

Thumbnail image of Clinical trial summary leave piece document.

ENTRESTO clinical trials

Download our leave piece to learn more about the study design, efficacy and safety data from five key ENTRESTO clinical trials.

 

Thumbnail image of Cardiologist infographic.

Cardiologist infographic

Download our step-by-step guide, which has been designed to highlight how ENTRESTO can help you better manage your patients with HFrEF upon hospital admission.

 

Thumbnail image of ENTRESTO Patient outcomes successes document.

Patient Outcomes and Successes

Download our leave piece outlining the data supporting quality of life benefits your patients could experience while on ENTRESTO vs ACEi (enalapril).

 

Thumbnail image of Top tips for reviewing patients with Chronic Heart Failure in a virtual consultation document.

Top tips for reviewing patients with chronic heart failure in a virtual consultation

Download this infographic, which is designed to give you top tips on how to get the most out of your virtual consultations with your adult patients who have been diagnosed with chronic HFrEF.

Download

 

Thumbnail image of ENTRESTO Northern health and social care trust ENTRESTO initiation checklist.

Northern Health and Social Care Trust ENTRESTO initiation checklist

Review this initiation checklist, independently developed by the Northern Health and Social Care Trust, which outlines practical considerations for the initiation, management and dose adjustment of ENTRESTO for inpatients.

Download

 

Thumbnail image of George Eliot hospital initiation checklist.

George Eliot Hospital initiation checklist

Review this initiation checklist, independently developed by the George Eliot Hospital Trust, which also outlines practical considerations for the initiation, management and dose adjustment of ENTRESTO for inpatients.

Download

 

Thumbnail image of NHS Lothian Heart Failure Protocol.

NHS Lothian Heart Failure Protocol

Download the Standard Drug Optimisation Protocol developed by the NHS Lothian Heart Failure Team, to learn about the optimisation strategy for the four medicines making up the cornerstone therapy for treating chronic HFrEF.

Download

 

Thumbnail image of CareMe Pathway.

CareMe UK Pathway

Download the recently updated CaReMe UK treatment algorithm for patients diagnosed with heart failure whereby ENTRESTO has been recommended as a first line treatment option for eligible chronic HFrEF patients.

Download

 

Thumbnail image of Affinity Care pathway document.

Bradford Affinity Care HF pathway

Download the Affinity Care heart failure pathway to better understand how to detect, diagnose, and manage your HF patients.

Download

 

Thumbnail image of Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies document.

Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies

Download the treatment algorithm developed by the ACC, which includes guidelines on initiating therapies to treat and manage a HFrEF diagnosis in your patients. You can also read the updated paper issued by the ACC in the following journal article: Maddox TM, et al. J Am Coll Cardiol 2021;77:772–810.

Download

 

Thumbnail image of Inpatient letter template.

Inpatient discharge letter template

Request a copy of an impatient letter template for you complete and hand over to your patient having been initiated on ENTRESTO. This letter is aimed at their primary care team, providing the rationale for ENTRESTO initiation, alongside guidance on managing the patient and treatment within the community.

Request a copy

 

Thumbnail image of Outpatient letter template.

Outpatient discharge letter template

Request a copy of an outpatient discharge letter template for you to complete and handover to your patient having on ENTRESTO. This letter is aimed at their primary care team, providing the rationale for ENTRESTO initiation, alongside guidance on managing the patient and treatment within the community.

Request a copy

 

Thumbnail image of HCP’s guide to MyEntresto document.

Your guide to ENTRESTO

Download our guide to treatment with ENTRESTO, outlining what to expect from this medicine, as well as hints and tips on managing your treatment.

 

Thumbnail image of Your Guide to ENTRESTO in hospital document.

Your in-hospital guide to ENTRESTO

This guide is for patients whom you have initiated on ENTRESTO as an inpatient. It also outlines what to expect from their treatment, as well as hints and tips on managing it upon their return home.

 

Thumbnail image of YourChoice Engage document.

MyEntresto and YourChoice Engage

This guide introduces the MyEntresto website, as well as the opt-in email communication programme designed for patients prescribed ENTRESTO. Both are aimed at supporting your patients along their treatment journey with ENTRESTO, to take ownership of managing their treatment and condition, to help improve adherence.

 

Small screen shots of two ENTRESTO guides the user will be able to download

MyEntresto patient website

Explore MyEntresto: our post-prescription patient website designed to support your patients with managing their condition and treatment, as well as possible side effects, in addition to useful hints and tips to support them with living with heart failure. Please note this is a non-promotional Novartis website that will open outside of this website.

Visit

 
 

Expert opinion on the implications of the British Society for Heart Failure position statement on Non-Medical Prescribing of Specialist Initiation Medicines in Heart Failure

Watch our expert speaker Dr Stephen Pettit, Consultant Cardiologist at Royal Papworth Hospital, give his perspective on the position statement, discussing what it captures and how it may impact practice.

 

 
 

Further resources for nurses:

Thumbnail image of HCP’s guide to MyEntresto document.

HCP’s guide to MyEntresto & YourChoice Engage

Request a copy for our introductory guide to MyEntresto & YourChoice Engage: our online patient resource designed to support you in empowering your patients to stay on top of their condition and treatment, with the aim of improving adherence. This outlines the key features of the platform, and how these can support your patients. 

 

Thumbnail image of British Society for Heart Failure (BSH) Statement document.

British Society for Heart Failure (BSH) Statement

Download a statement from the BSH which highlights their held position on non-medical prescribing of specialist initiation medicines in cases of patients with heart failure.

Thumbnail image of top tips document.

Top tips for heart failure specialist nurses

This infographic aimed at heart failure specialist nurses (HFSNs) provides top tips for reviewing patients with chronic heart failure in a virtual consultation.

 

Thumbnail image of heart to heart logo and podcast icon.

Resources for nurses: The Heart to Heart podcast series

Listen to our podcast series made specifically to provide support to heart failure specialist nurses who are facing particular challenges in their current practice. Discussion topics include the role of a HFSN, how guidelines can help empower you with prescribing ENTRESTO, the importance of early patient identification, effective patient management across primary, secondary and community services, and as well as psychological support for your patients.

 

Heart to heart icon and text

Resources for GP’s

Watch a selection of useful videos on creating referral letters, reports and alerts in the GP system
 

View

 Small screen shot of a video reel

Medical Experts Talking Heads

Watch a selection of videos on heart failure and its management
 

View

 
 

 

Indication: Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.1

HCP, healthcare professional; HFrEF, heart failure with reduced ejection fraction.

Reference     

  1. ENTRESTO® Summary of Product Characteristics. Accessed on May 2024 www.medicines.ie

     

Rate this content: 
No votes yet
April 2022 | IE 172569
×

Ask Speakers

×

Medical Information Request

Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.